Clinical Trial

Neuro Biomarkers of Smoking Behavior

Study Description

Neuro Biomarkers of Smoking Behavior

The purpose of this study is to evaluate cognition in smokers and nonsmokers. It involves administration of intranasal insulin (Novolin R), an investigational medication followed by a brief non-invasive cognitive test, during which brain waves are recorded. All participants will receive both Novolin R and placebo in two separate testing sessions.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Novolin R

Novolin R is a sterile, clear, aqueous, and colorless solution that contains human insulin (rDNA origin) 100 units/mL, glycerol 16 mg/mL, metacresol 3 mg/mL, zinc chloride approximately 7 mcg/mL and water for injection. The pH (potential Hydrogen) is adjusted to 7.4. Hydrochloric acid 2N (concentration) or sodium hydroxide 2N may be added to adjust pH. Novolin R vials are latex-free. The drug substance is being purchased from McKesson.

Additional Information

Official Study Title

Neurologic Biomarkers of Smoking Behavior

Clinical Trial ID

NCT03811951

ParticipAid ID

bkRBYa